Background
and study aim: Hepatocellular carcinoma (HCC) is currently the fifth most common solid tumor worldwide and the third leading cause of cancer-related death. Percutaneous ethanol injection (PEI) and radiofrequency ablation (RFA) techniques became well-known procedures for controlling small HCC. Inflammation is a major contributing factor to carcinogenesis specially HCC. Inflammatory mediators including interleukin-6 (IL-6) and neutrophil to lymphocyte ratio (NLR) are good candidates to stimulate tumor growth and progression. The aim of this study was to evaluate validity of using NLR and IL-6 as predictors of outcome of interventional treatment for HCC.
Patients and methods:
This study was conducted on 136 patients with 145 focal nodular HCCs of 5 cm or less between 2012 and 2015. They were divided into 2 groups, the first group included 72 patients whom had NLR less than 5 and the second group included 64 patients whom had NLR equal or more than 5. Patients underwent PEI or RFA. Clinical assessment, laboratory evaluation and triphasic CT studies were performed to all patients pre-treatment and at 1, 6 and 12 months post treatment. NLR and IL-6 level were performed to all patients pre treatment and at 6 months post treatment.
Results:
The percentage of complete ablation is highly significantly higher in group I after 1 month but, there is no significant difference between outcome of treatment after 1 year in both groups one year after treatment. Post-procedural IL-6 showed highly significantly lower levels in patients whose focal lesions remain ablated till 1 year than in those who showed multifocal or local recurrence, while NLR did not show significant difference among these groups. Postprcedural IL-6 levels were highly significantly lower in survived than died cases, while NLR did not show significant differences between both groups at 1 year follow up. There was no significant difference in the post-procedural level of NLR or IL-6 between the group who was treated with ethanol injection and who was treated with radiofrequency ablation as regard the overall outcome at 1 year follow up. The aim of this study was to evaluate validity of using NLR and IL-6 as predictors of outcome of interventional treatment for HCC. Group II: Contained 64 patients with 70 focal lesions (58 patients had single lesion and 6 patients each had 2 lesions). These patients had NLR equal or more than 5.
INTRODUCTION

PATIENTS AND METHODS
The diagnosis of HCC in a patient with hepatic focal lesion was based on triphasic CT scan showing typical criteria for HCC (early enhancement during arterial phase followed by washout of contrast in porto-venous and delayed phases). Patients with Child-Pugh class C, vascular invasion, extrahepatic metastasis and the patients with coexistent haematological disorders or known active infection (affecting total or differential leucocytic count) were excluded.
A written informed consent was taken from all included patients, and the ethical committee of the university has accepted the study.
Pretreatment assessment
Pre treatment assessment of all patients was done by full history taking, thorough clinical examination, laboratory investigations including liver function, kidney function, Complete blood count including total and differential WBC counts, α fetoprotein, serological markers for HCV and HBV, NLR (was calculated from the differential count by dividing the absolute neutrophil count by the absolute lymphocyte count) and IL-6 measurement. Radiological examination including ultrasound and triphasic CT study. In our study the percentage of complete ablation is highly significantly higher in group I while, the percentage of partial ablation is highly significantly higher in group II.
RESULTS
In our study the percentage of stationary outcome is significantly higher in group I. Otherwise; other outcomes do not show significant differences between both groups as shown in table (2). There is a significant direct correlation between the mean pre-procedural NLR with bilirubin and prothrombin time and a highly significant direct correlation with age and diameter of focal lesion and a highly significant indirect correlation with hemoglobin and platelet count. There is high significant difference between stationary, multifocal and local recurrence groups as outcome after one year as regard post-procedural IL-6. There is high significant difference between survived and died groups after one year as regard postprocedural IL-6.
DISCUSSION
Till the time this study is planned for in October 2012, many studies had been published to evaluate validity of using either NLR or IL-6 as predictors of outcome of interventional treatment for HCC but -to our knowledge-no studies including both NLR and IL6 in the same study.
Jang and collegues showed that IL-6 was the most significant cytokine predictive of HCC survival. A high serum IL-6 level appeared to reflect the tumor burden, because it was significantly associated with tumor size, stage and aggressiveness such as portal vein invasion and metastasis [21]. Kim and collegues measured the level of 13 member of cytokine family in HCC patients and found that Among the 13 cytokines tested in this study, IL-6 was most strongly related to tumor characteristics including tumor size, number, and the presence of metastasis suggesting a significant role of IL-6 in HCC progression [22] .
In this study, the patients in group II (NLR ≥5) are highly significantly older than group I (NLR <5 There was no significant correlation between the mean preprocedural IL-6 and Child-Pugh classes in agreement with Parasole et al. [30] and not in agreement with Kim et al [22] who measured the level of 13 member of cytokine family in Korean HCC patients and found significant association between IL-6 and Child-Pugh class.
The liver profile tests were more deranged in patients with elevated NLR who showed more derangement after locoregional treatment than patients with normal NLR. Patients with elevated NLR showed also elevation in serum creatinine after locoregional treatment which is absent in patients with normal NLR.
Although the impaired synthetic function accompanying chronic liver disease is a main determinant of reduced serum albumin, this reduction also reflects subclinical inflammatory response and malnutrition. These overlapping conditions affect the prognosis of cancer patients.
Hepatic albumin biosynthesis is downregulated by proinflammatory stimuli as part of a negative acute phase reaction, in patients with malignancy [40] . This is obvious in this study where serum albumin significantly reduced after ethanol injection or radiofrequency ablation in both groups. The cell death that occur after these maneuvers leads to production of macromolecules called damage associated molecular patterns (DAMPs) that trigger the production of cytokines and other proteins that regulate and amplify the inflammatory response with its consequences [4].
There was a significant direct correlation between the mean preprocedural NLR and bilirubin and prothrombin time. Hemoglobin and platelet count were highly significantly lower in group II before and after procedure while, after procedure there were highly significant lowering in hemoglobin, platelet count and white blood cells count in both groups. There was a highly significant indirect correlation between the mean preprocedural NLR and hemoglobin concentration and platelet count.
That was not in agreement with Fu et al. [31].
In this study alpha fetoprotein showed highly significant decrease in group I and significant decrease in group II after procedure while no significant difference in its level between both groups either before or after procedures. Neither preprocedural NLR or IL-6 showed any correlation with alpha fetoprotein in agreement with Motomura et al. After procedure, IL-6 increased in group I and decreased in group II insignificantly and there was highly significant difference in the level of postprocedural IL-6 between both groups in agreement with Chau et al. [24] but not in agreement with Erinjeri et al. [34] . Both studies showed change in the level of IL-6 but no study of them classified patients from the start according to NLR.
The percentage of complete ablation was highly significantly higher in group I while, the percentage of partial ablation was highly significantly higher in group II in agreement with Fu et al. [31] The percentage of stationary outcome was significantly higher in group I than group II 6 months after procedure while, one year after procedure there was no significant difference between outcome of complete ablation in both groups. Also follow up of all patients in both groups one year after procedures showed that there was no significant difference as regard outcome of procedures in both groups. The mean preprocedural NLR levels did not show significant difference between groups with different outcomes not in agreement with Liao et al. [23] who studied 256 HCC patients underwent surgery with longer duration of follow up. IL-6 levels did not show any significant difference between groups with different outcomes in agreement with Pang et al. [25] .
There was no significant difference in one year survival between both groups. Also there was no significant difference in the mean preprocedural NLR between the survived and died groups in agreement with Fu et al. [31] In this study, the measurement of NLR and IL-6 was done after six months after procedure in order to limit the influence of post procedure inflammation on the results. A study made by Erinjeri et al. [34] showed that percutaneous thermal ablation in HCC patients invokes an inflammatory response that is characterized by elevation in the plasma levels of specific cytokines. IL-6 and IL-10 show the most robust increases in plasma levels within 48 hours of ablation. Also they showed that in patients undergoing image-guided ablation, heat-based ablation techniques showed 3.5 fold increases in IL-6 levels compared with a 54 fold increase with cryoablation. Some researchers showed that after open surgical radiofrequency ablation of hepatic malignancy, IL-6 levels increased 4 fold and after open hepatic cryoablation, IL-6 levels increased more than 100 fold [41,42].
The postprocedural IL-6 showed highly significant difference among patients with different outcomes at one year follow up while, postprocedural NLR did not show any significant difference among different outcomes or survived and died groups. So, postprocedural IL-6 could be considered as a good predictor not only for survival, but also for efficacy of treatment in agreement with Wong et al. [43] who proved that patients with hepatitis B and a high plasma level of IL-6 have HCC free survival three times shorter than patients with low IL-6 levels, even after controlling for age, gender, cirrhosis, use of antiviral treatments, hepatitis B virus DNA, and peak alanine aminotransferase levels. This is not in agreement with Chau et al. Induced immune response after interventional procedure is mostly weak, and not sufficient for the complete eradication of established tumors or durable prevention of disease progression, but it could produce a favorable effect on the outcome and survival Dan et al. [46] but in some patients, the balance between host inflammatory response and immune response is tipped in favor of protumor inflammatory response where IL-6 remain high or increased after interventional treatment and predicts poor oncologic outcome. In this group of patients, it is reasonable to manipulate the systemic inflammatory response through targeted anti-inflammatory mediators such as IL-6 blocking antibodies Chua et al. [26] . There was no significant difference in the postprocedural level of NLR or IL-6 between the group who was treated with ethanol injection and who was treated with radiofrequency ablation as regard the overall outcome at 1 year follow up.
The conflict between results of different studies of NLR or IL-6 may be attributed to differences in age, performance status, Child-Pugh classes as some studies included Child C, different races and population, different criteria of selection of HCC patients as presence of metastasis, portal vein invasion, larger diameter of focal lesions or different alpha fetoprotein levels, different predisposing factors of HCC including different serology of viral hepatitis, also use of different lines of treatment as percutaneous ablation, transarterial chemoembolization, systemic chemotherapy, hepatic resection, sorafenib, liver transplantation or mixed lines of treatment.
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